Brief: Seelos Therapeutics Receives Research And Development Grant From Michael J. Fox Foundation For Parkinson's Research For SLS-004
24/08/2022 13:04
Aug 24 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS RECEIVES A RESEARCH AND DEVELOPMENT
GRANT
FROM THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH FOR
SLS-004
Source text for Eikon: ID:nPn7mxzcta
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio